Early phase studies with paclitaxel/low-dose carboplatin in patients with solid tumors

Seminars in Oncology

Volumn 23, Issue 6 SUPPL. 16, 1996, Pages 26-31

  Creaven, P J ^a   Raghavan, D ^a   Perez, R P ^a   Pendyala, L ^a   Berghorn E J , Jr ^a   Loewen, G ^a   Meropol, N J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ADULT; AGED; AREA UNDER THE CURVE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; MALE; MAXIMUM PERMISSIBLE DOSE; NEUROTOXICITY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SOLID TUMOR; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; DRUG TOLERANCE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; NEOPLASMS; PACLITAXEL; TREATMENT OUTCOME;

EID: 0030460169     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)